PTPRC and neoplasm: FCM results indicated that treatment with FMT+β-glucan did not alter the infiltration of MDSCs (CD45+CD11b+Gr-1+) compared to that in the control group and solo treatment, but increased the ratio of total macrophages (CD11b+F4/80+ in CD45+ cells) and M1-type macrophages in tumor tissues (Figure 1H-L).